Trial Profile
Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2020
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary)
- Indications Bacteraemia; Septicaemia; Staphylococcal infections
- Focus Therapeutic Use
- Acronyms DASH
- 15 Jul 2020 Primary endpoint has not been met. (Blood culture clearance)
- 15 Jul 2020 Results published in the Clinical Infectious Diseases
- 27 Feb 2020 Status changed from active, no longer recruiting to completed.